Caffeic acid phenethyl ester suppresses the induction of eotaxin in human lung fibroblast cells

Journal of Asthma

Volumn 47, Issue 3, 2010, Pages 233-237

  Liao, Yu Ru ^a   Hsu, Jen Yuan ^a   Chu, Jao Jia ^a   Fu, Lin Shien ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Caffeic acid phenethyl ester; Eotaxin; IL 13; Lung fibroblasts; TNF ; Transcriptional factor

Indexed keywords

CAFFEIC ACID PHENETHYL ESTER; CINTREDEKIN BESUDOTOX; EOTAXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; LUNG FIBROBLAST; WESTERN BLOTTING;

CAFFEIC ACIDS; CELLS, CULTURED; CHEMOKINE CCL11; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; HUMANS; INTERLEUKIN-13; LUNG; NF-KAPPA B; PHENYLETHYL ALCOHOL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77951099574     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770900903556405     Document Type: Article

References (30)

1. Pauwels R. The relationship between airway inflammation and bronchial hyperresponsiveness. Clin Exp Allergy 1989; 19:395-398.
2. Jose PJ, Griffiths-Johnson DA, Collins PD,Walsh DT, Moqbel R, Totty NF, Truong O, Hsuan JJ, Williams TJ. Eotaxin: A potent eosinophil chemoattracttant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 1994; 179:881-887.
3. Collins PD, Marleau S, Griffiths-JohnsonDA, Jose PJ,WilliamsTJ. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 1995; 182:1169-1174.
4. Ponath PD, Qin S, Post TW, Wang J, Wu L, Gerard NP, Newman W, Gerard C, Mackay CR. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med 1996; 183:2437-2448.
5. Jedrzkiewicz S, Nakamura H, Silverman ES, Luster AD, Mansharamani N, In KH, Tamura G, Lilly CM. IL-1beta induces eotaxin gene transcription in A549 airway epithelial cells through NF-kappaB. Am J Physiol Lung Cell Mol Physiol 2000; 279:L1058-L1065.
6. Marini M, Vittori E, Hollemborg J, Mattoli S. Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. J Allergy Clin Immunol 1992; 89:1001-1009.
7. Rothenberg ME, Luster AD, Leder P. Murine eotaxin: An eosinophil chemoattractant inducible in endothelial cell and in interleukin-4 induced tumor suppression. Proc Natl Acad Sci U S A 1995; 92:8960-8964.
8. Teran LM, Mochizuki M, Bartels J, Valencia EL, Nakajima T, Hirai K, Schroder JM. Th1- and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts.AmJ Respir Cell Mol Biol 1999; 20:777-786.
9. Terada N, Hamano N, Nomura T, Numata T, Hirai K, Nakajima T, Yamada H, Yoshie O, Ikeda-Ito T, Konno A. Interleukin-13 and tumour necrosis factor-alpha synergistically induce eotaxin production in human nasal fibroblasts. Clin Exp Allergy 2000; 30:348-355.
10. Lilly CM, Nakamura H, Kesselman H, Nagler-Anderson C, Asano K, Garcia-Zepeda EA, Rothenberg ME, Drazen JM, Luster AD. Expression of eotaxin by human lung epithelial cells: Induction by cytokines and inhibition by glucocorticoids. J Clin Invest 1997; 99:1767-1773.
11. Sato E, Nelson DK, Koyama S, Hoyt JC, Robbins RA. (2000) Bradykinin stimulates eotaxin production by a human lung fibroblast cell line. J Allergy Clin Immunol 2000; 106(1 Pt 1):117-123.
12. Hayashi R, Yamashita N, Matsui S, Maruyama M, Sugiyama E, Sugiyama S, Kobayashi M. Bradykinin stimulates interleukin-8 production by human lung fibroblasts. Immunology. 1998; 95:507-511.
13. KumagaiN, Fukuda K, Ishimura Y, Nishida T. (2000) Synergistic induction of eotaxin expression in human keratocytes by TNF-alpha and IL-4 or IL-13. Invest Ophthalmol Vis Sci 2000; 41:1448-1453
14. Roy B, Bhattacharjee A, Xu B, Ford D, Maizel AL, Cathcart MK. IL- 13 signal transduction in human monocytes: Phosphorylation of receptor components, association with Jaks, and phosphorylation/activation of Stats. J Leukoc Biol 2002; 72:580-589.
15. Fesen MR, Pommier Y, Leteurtre F, Hiroguchi S, Yung J, Kohn KW. Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. Biochem Pharmacol 1994; 48:595-608.
16. Grunberger D, Banerjee R, Eisinger K, Oltz EM, Efros L, Caldwell M, Estevez V, Nakanishi K. Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis. Experientia 1998; 44: 230-232.
17. Guarini L, Su ZZ, Zucker S, Lin J, Grunberger D, Fisher PB. Growth inhibition and modulation of antigenic phenotype in human melanoma and glioblastoma multiforme cells by caffeic acid phenethyl ester (CAPE). Cell Mol Biol 1992; 38:513-527.
18. Su ZZ, Lin J, Grunberger D, Fisher PB. Growth suppression and toxicity induced by caffeic acid phenethyl ester (CAPE) in type 5 adenovirustransformed rat embryo cells correlate directly with transformation progression. Cancer Res 1994; 54:1865-1870.
19. Natarajan K, Singh S, Burke TR Jr, Grunberger D, Aggarwal BB. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc Natl Acad Sci U S A 1996; 93:9090-9095.
20. Mahon TM, O'Neill LA. Studies into the effect of the tyrosine kinase inhibitor herbimycin A on NF-kappa B activation in T lymphocytes. Evidence for covalent modification of the p50 subunit. J Biol Chem 1995; 270:28557-28564.
21. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:13580-13584.
22. Li L, Xia Y, Nguyen A, Lai YH, Feng L, Mosmann TR, Lo D. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol 1999; 162:2477-2487.
23. Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P, Luster AD. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med 1996; 2:449-456.
24. Spoelstra FM, Postma DS, Kauffman HF. Mutual activation of pulmonary fibroblasts and eosinophils, and modulation by drugs in relation to asthma. Clin Exp Allergy 2001; 31:808-816.
25. Yang L, Cohn L, Zhang DH, Homer R, Ray A, Ray P. Essential role of nuclear factor kappaB in the induction of eosinophilia in allergic airway inflammation. J Exp Med 1998; 188:1739-1750.
26. Barnes PJ,Adcock IM. Transcription factors and asthma. Eur Respir J 1998; 12:221-234.
27. Matsukura S, Stellato C, Plitt JR, Bickel C, Miura K, Georas SN, Casolaro V, Schleimer RP. Activation of eotaxin gene transcription by NFkappa B and STAT6 in human airway epithelial cells. J Immunol 1995; 163:6876-6883.
28. Matsukura S, Stellato C, Georas SN, Casolaro V, Plitt JR, Miura K, Kurosawa S, Schindler U, Schleimer RP. (2001) Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a STAT6- dependent mechanism. Am J Respir Cell Mol Biol 2001; 24:755-7561.
29. OdakaM,Matsukura S, Kuga H, et al. Differential regulation of chemokine expression by Th1 and Th2 cytokines and mechanisms of eotaxin/CCL-11 expression in human airway smoothmuscle cells. Int Arch Allergy Immunol 2007; 143(Suppl 1):84-88.
30. Thieu VT, Nguyen ET, McCarthy BP, Bruns HA, Kapur R, Chang CH, Kaplan MH. IL-4-stimulated NF-kappaB activity is required for Stat6 DNA binding. J Leukoc Biol 2007; 82:370-379.